SBLOF (Shin Nippon Biomedical Laboratories) Beginning Cash Position: $0.0 Mil (As of Mar. 2026)


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
74 GF Score
Price $9.16
GF Value $13.86
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Beginning Cash Position?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 74 Beginning Cash Position is $0.0 Mil as of Mar. 2026. GuruFocus rates SBLOF with a GF Score™ of 74/100 and a GF Value™ of $13.86. The stock has 5 warning signs investors should review.

Shin Nippon Biomedical Laboratories's Beginning Cash Position for the quarter that ended in Mar. 2026 was $0.0 Mil.

Shin Nippon Biomedical Laboratories's annual Beginning Cash Position increased from Mar. 2024 ($61.4 Mil) to Mar. 2025 ($68.5 Mil) and increased from Mar. 2025 ($68.5 Mil) to Mar. 2026 ($74.6 Mil).

Shin Nippon Biomedical Laboratories Beginning Cash Position Related Terms

Shin Nippon Biomedical Laboratories Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories Beginning Cash Position Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.39 34.02 61.39 68.54 74.64

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SBLOF
74GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.0 Mil mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a Beginning Cash Position of $0.0 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shin Nippon Biomedical Laboratories and its competitors.
Is Shin Nippon Biomedical Laboratories' Beginning Cash Position too high?
Shin Nippon Biomedical Laboratories' current Beginning Cash Position is $0.0 Mil. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Beginning Cash Position compare to TMO and DHR?
Shin Nippon Biomedical Laboratories' Beginning Cash Position of $0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current Beginning Cash Position is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current Beginning Cash Position of $0.0 Mil. The stock's GF Value™ is $13.86, compared to a current price of $9.16 — trading 33.9% below its estimated fair value. The current Beginning Cash Position is $0.0 Mil. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current Beginning Cash Position is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 33.9% below its estimated GF Value™ of $13.86.

Key valuation signals for SBLOF:

  • Beginning Cash Position: $0.0 Mil
  • GF Value™: $13.86 vs. price of $9.16 (33.9% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score

Get the complete analysis for SBLOF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$13.86
GF Value